Cargando…

A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells

The main reason why peritoneal dialysis (PD) still has limited use in the management of patients with end-stage renal disease (ESRD) lies in the fact that the currently used glucose-based PD solutions are not completely biocompatible and determine, over time, the degeneration of the peritoneal membr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piccapane, Francesca, Bonomini, Mario, Castellano, Giuseppe, Gerbino, Andrea, Carmosino, Monica, Svelto, Maria, Arduini, Arduino, Procino, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795315/ https://www.ncbi.nlm.nih.gov/pubmed/33374405 http://dx.doi.org/10.3390/ijms22010123

Ejemplares similares

Aquaporin-1 Facilitates Transmesothelial Water Permeability: In Vitro and Ex Vivo Evidence and Possible Implications in Peritoneal Dialysis
por: Piccapane, Francesca, et al.
Publicado: (2021)

How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient’s Health)
por: Bonomini, Mario, et al.
Publicado: (2021)

Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2019)

Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis
por: Masola, Valentina, et al.
Publicado: (2021)

A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021)

AQP1-Containing Exosomes in Peritoneal Dialysis Effluent As Biomarker of Dialysis Efficiency
por: Corciulo, Simone, et al.
Publicado: (2019)

Role of Lamin A/C Gene Mutations in the Signaling Defects Leading to Cardiomyopathies
por: Gerbino, Andrea, et al.
Publicado: (2018)

Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
por: Milano, Serena, et al.
Publicado: (2017)

The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)

Pro‐inflammatory cytokines as emerging molecular determinants in cardiolaminopathies
por: Gerbino, Andrea, et al.
Publicado: (2021)

Proteomic Research in Peritoneal Dialysis
por: Bonomini, Mario, et al.
Publicado: (2020)

Dandelion Root Extract Induces Intracellular Ca(2+) Increases in HEK293 Cells
por: Gerbino, Andrea, et al.
Publicado: (2018)

Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study
por: Vecchi, Luigi, et al.
Publicado: (2021)

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

The expression of Lamin A mutant R321X leads to endoplasmic reticulum stress with aberrant Ca(2+) handling
por: Carmosino, Monica, et al.
Publicado: (2016)

β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
por: Milano, Serena, et al.
Publicado: (2023)

Spilanthol from Acmella Oleracea Lowers the Intracellular Levels of cAMP Impairing NKCC2 Phosphorylation and Water Channel AQP2 Membrane Expression in Mouse Kidney
por: Gerbino, Andrea, et al.
Publicado: (2016)

β(3) adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
por: Procino, Giuseppe, et al.
Publicado: (2016)

Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome
por: De Zio, Roberta, et al.
Publicado: (2019)

Publisher Correction: Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka
por: Gerbino, Andrea, et al.
Publicado: (2020)

Role of PKC in the Regulation of the Human Kidney Chloride Channel ClC-Ka
por: Gerbino, Andrea, et al.
Publicado: (2020)

Activation of the Thiazide-Sensitive Sodium-Chloride Cotransporter by Beta3-Adrenoreceptor in the Distal Convoluted Tubule
por: Milano, Serena, et al.
Publicado: (2021)

High-throughput fluorescent-based NKCC functional assay in adherent epithelial cells
por: Carmosino, Monica, et al.
Publicado: (2013)

Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis
por: Shimizu, Satoshi, et al.
Publicado: (2019)

Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
por: Lee, Hi Bahl, et al.
Publicado: (2007)

Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X
por: De Zio, Roberta, et al.
Publicado: (2022)

Targeting unfolded protein response reverts ER stress and ER Ca(2+) homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X
por: Pietrafesa, Giusy, et al.
Publicado: (2023)

Acetate trafficking in the heart: carnitine acyltransferases matter
por: Zammit, Victor, et al.
Publicado: (2016)

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)

Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis
por: Kang, Duk-Hee
Publicado: (2020)

Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells
por: Bonomini, Mario, et al.
Publicado: (2016)

TRPML1-Induced Lysosomal Ca(2+) Signals Activate AQP2 Translocation and Water Flux in Renal Collecting Duct Cells
por: Scorza, Simona Ida, et al.
Publicado: (2023)

Dissolved molecular hydrogen (H(2)) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Transcriptome analysis of signaling pathways of human peritoneal mesothelial cells in response to different osmotic agents in a peritoneal dialysis solution
por: Liu, Bin, et al.
Publicado: (2019)

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes
por: Cho, Yeoungjee, et al.
Publicado: (2012)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients
por: Ruiz-Carpio, Vicente, et al.
Publicado: (2017)

Activation of salt-inducible kinase 2 promotes the viability of peritoneal mesothelial cells exposed to stress of peritoneal dialysis
por: Wang, H-H, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ogh4k2o9sq00sc3acckldt2u9